Article Figures & Tables
Figures
Figure 1: Flow of patients through the randomized controlled trial.
Figure 2: Levels of tetrahydrocannabinol (THC) in plasma after inhalation of a single dose. Data are presented as means and standard deviations.
Tables
Table 1: Demographic and baseline characteristics of participants
Table 2: Pairwise comparisons of the effects of four potencies of smoked cannabis on average daily pain
Table 3: Effects of smoked cannabis and secondary outcomes, by potency of tetrahydrocannabinol (THC) received
Table 4: Adverse events reported during the study, by potency of tetrahydrocannabinol (THC) (part 1 of 2)
Table 4: Adverse events reported during the study, by potency of tetrahydrocannabinol (THC) (part 2 of 2)
In this issue
Article tools
Respond to this article
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
Jump to section
Related Articles
Cited By...
- Matched pilot study examining cannabis-based dronabinol for acute pain following traumatic injury
- Cannabis for peripheral neuropathy: The good, the bad, and the unknown
- Medical marijuana research
- Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials
- Cannabis in the Treatment of Rheumatic Diseases: Suggestions for a Reasoned Approach
- Prescribing smoked cannabis for chronic noncancer pain: Preliminary recommendations
- Prescrire du cannabis fume pour la douleur chronique non cancereuse: Recommandations preliminaires
- Impact of Efficacy at the {mu}-Opioid Receptor on Antinociceptive Effects of Combinations of {mu}-Opioid Receptor Agonists and Cannabinoid Receptor Agonists
- New medical marijuana regulations: the coming storm
- Marijuana is not a prescription medicine
- Identification of olivetolic acid cyclase from Cannabis sativa reveals a unique catalytic route to plant polyketides
- Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
- Cannabis and Its Derivatives: Review of Medical Use